Background/Aims: CTLA4 has been identified functioning as a protein receptor which functions as an immune checkpoint, downregulating the immune system. Susceptibility to aggressive periodontitis (AgP) is influenced by gene polymorphisms related to the immune response. In this study, we focused on SNPs in the 3'-UTR of CTLA4 among Chinese AgP patients, and investigated any further relationships between the SNPs and miRNAs. Methods: This case-control study included 120 AgP patients and 150 healthy controls. Genotyping was used to detect allele distribution. Cell transfection and the dual luciferase reporter assay were performed to investigate the potential functions of SNPs located in the 3'UTR of CTLA4. Results: The data show that patients with a history of smoking were more susceptible compared to controls, exhibiting deeper probing depth, greater attachment loss and more sites of bleeding on probing. The results of genotyping analysis revealed that individuals with the GA and AA genotypes, and with the A carrier had a decreased risk (P = 0.015, P = 0.03). Furthermore, patients with the G allele might be regulated by miR-105, which caused a down-regulation of CTLA4. The carriers of the GG genotype exhibited the worst results of attachment loss and bleeding on probing. Conclusion: These findings show that rs56102377 in the 3'-UTR of CTLA4 may act as a protective factor by disrupting the regulatory role of miR-105 in CTLA4 expression. Thus, our study highlighted a potential role of these polymorphisms as genetic susceptibility biomarkers of periodontitis in Chinese Han populations.
Introduction
Characterized by a destructive inflammatory process, periodontal disease is a multifactorial infectious inflammatory condition which affects the tooth-supporting tissues, resulting in periodontal pocket formation, alveolar bone resorption and eventually tooth loss [1, 2] . It has been demonstrated that environmental factors such as hormones, drugs or diet modify preexisting periodontal conditions [3] . Among these factors, smoking is considered one of the main risk factors for periodontitis. Smoking affects the oral environment, gingival vasculature, and inflammatory and immunological responses, as well as the healing potential of periodontal connective tissues [4, 5] .
Recent studies have demonstrated that inflammatory cytokines, including IL-1, IL-6, TNF-alpha and IFN-gamma, are risk factors for aggressive periodontitis [6] [7] [8] . The relationship between host immune response and periodontal pathogens plays a critical role in periodontal tissue breakdown [9, 10] . Protective and destructive immune responses play a great role in the pathogenesis of periodontitis and attachment loss. Thus, relationships between genes regulating the immune responses and periodontitis seem to be intuitively reasonable [11] . Cytotoxic T-lymphocyte antigen 4 (CTLA4), encoded by the gene CTLA4, belongs to the immunoglobulin supergene family [12] . In recent years, the relationship between CTLA4 polymorphisms and some diseases such as Graves' disease and hepatocellular carcinoma has attracted extensive attention [13, 14] . Previous studies indicated that CTLA4 polymorphisms were closely related to various autoimmune diseases such as idiopathic dilated cardiomyopathy and lupus erythematous as well as thyroid diseases [15, 16] . In addition, T (-) in CD28 + 17 (T/C) and A (+) in CTLA4 +49 (A/G) genotypes are associated with susceptibility to aggressive periodontal disease and CTLA4 gene variants might be associated with susceptibility to a specific form of periodontitis [17] . However, most of the SNPs reported in CTLA4 are located in the coding region; the association of any SNPs located in the non-coding region, especially the 3' untranslated region (UTR), has been poorly investigated. The 3-UTR frequently interacts with microRNAs (miRNAs; non-coding RNA molecules of 19-25 nucleotides) [18, 19] . The miRNAs negatively regulate expression of their target genes at the posttranscriptional level through binding to 3' UTRs of their targets' messenger RNAs (mRNAs) [20, 21] .
Based on the investigations mentioned above, we hypothesized that SNPs in the 3'UTR of CTLA4 may play a role in regulating CTLA4 expression, which may be associated with the pathogenesis of periodontitis. We identified all the SNPs which could be regulated by miRNAs as candidate SNPs by using bioinformatics software (http://www.bioguo.org/miRNASNP/), and the allele distribution was then further investigated in this case-control study.
Materials and Methods

Study subjects
This hospital-based case-control study consists of 120 patients newly diagnosed as AgP and 150 healthy controls. All the subjects were genetically unrelated Han Chinese, recruited from the department of Periodontics, Affiliated Stomatological Hospital of Nanjing Medical University between January 2012 and February 2016. The periodontal examination included determination of probing depth (PD), clinical attachment loss (CAL), bleeding on probing (BOP). The subjects who had directly smoked more than 10 cigarettes daily for 5 years were considered as smokers. Measurements of PD and CAL were recorded to the nearest 1 mm, with measures between 1 mm probe markings rounded down to the nearest length. Measurements were performed at 6 sites per tooth (mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual, and distolingual). None of patients had a history of current manifestation of systemic diseases. Patients with severe medical disorders (diabetes mellitus, immunological disorders, hepatitis, Cellular Physiology and Biochemistry
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HIV infection, and cardiovascular involvement), use of orthodontic appliances, need for premedication for dental treatment, chronic usage of anti-inflammatory drugs, present acute necrotizing ulcerative gingivitis, and pregnant or lactating woman were excluded from the study. The patients were classified according to World Health Organization classification. This study was approved by Ethics Committee of Nanjing Medical University, every patient had written informed consent.
Genotype
The genomic DNA obtained from peripheral whole blood of every validation subject was extracted by using QIAamp DNA blood mini kits (QIAGEN, CA, USA) according to the manufacturer's instructions. Genotyping was performed by the TaqMan SNP Genotyping Assay, the PCR reactions were carried out in a total volume of 5 μL containing TaqMan Universal Master Mix, 80X SNP Genotyping Assay Mix, Dnase-free water and 10 ng genomic DNA. The PCR conditions were 2 min at 50°C, 10 min at 95°C, followed by 40 cycles at 95°C for 15 sec and 60°C for 1 min, by using the 384-well ABI 7900HT Real Time PCR System (Thermo, CA, USA).
Real time PCR assay
Real time polymerase chain reaction (RT-PCR) was performed to determine the expression level of miR-105. The probe for detecting the expression of miR-105 was ordered from Thermo Fisher Scientific with the Cat. # A25576. The amplification conditions were 95°C for 10 minutes, followed by 40 cycles of 95°C for 30 seconds, 55°C for 40seconds, and 72°C for 30 seconds, and finally 4°C for 30 minutes for cooling with the same PCR system mentioned above. The primers for miR-105 were: Forward 5′-GCCCTCG AGATA CC AT ATCTATCCCCTTTTTCA-3′; Reverse 5′-GCCGAATTC CAACCATGA AGAT A CGAATTGATG-3. Primers for GAPDH were: Forward: 5′-GACTCATGACCACAGTCCATGC-3′; Reverse: 3′-A GAGG CAGGGATGATGTTCTG-5′.
Cell lines and cell culture
Periodontal ligament cell line (PDLC) was purchased from the Science (Science, CA, USA) with the Catalog #2630. Cells were cultured in Dulbecco Modified Eagle Medium (Gibco, NY, USA) supplemented with 10% fetal bovine serum (Invitrogen, CA, USA) and grown in humidified 5% CO 2 at 37˚C. The miR-105 mimics and normal control were obtained from Genepharma (Shanghai, China). The transfection was conducted by using Lipofectamine 2000 (Invitrogen, CA, USA).
Dual-luciferase reporter gene assay
The full length of gene CTLA4 containing either G or A allele was amplified. The PCR productions were cloned into the pGL3-luciferase-based plasmid (Promega, CA, USA). The amplified fragments were verified by DNA sequencing. For reporter assay, cells were plated onto 24-well plates and transfected with 100 ng of wild type pGL3-CTLA4, mutant type pGL3-CTLA4 and miR-105 mimics, respectively by using Lipofectamine 2000 (Invitrogen, CA, USA). A Renilla luciferase vector pRL-SV40 (5 ng) was also co-transfected to normalize the differences in transfection efficiency. Transfection was performed three times in triplicate.
Statistical analysis
For evaluating the association between rs56102377 genotypes and the risk of AgP, the odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated by using univariates and multivariate logistic regression analysis. Stratification analysis was performed according to the clinical characteristic and risk classification to determine the genotype distribution as well as their associations with the risk of AgP. All statistical tests were two-sided and P<0.05 was considered statistically significant. Statistical analysis was performed with Stata10.0 and SAS9.1 software. The graphs were generated by GraphPad Prism 6.0.
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Results
Study population
The clinical characteristics of all the cases and controls are presented in Table 1 . As shown, the study population included 120 AgP patients (65 males, 55 females; age range 19-38 years) and 150 healthy controls (79 males, 71 females; age range 17-50 years). The gender distribution was reasonably well balanced in AgP patients and controls (P = 0.806). The patient population exposed to smoking was indicated to be more susceptible in comparison to controls. The AgP patients exhibited deeper probing depth, more attachment loss and more sites of bleeding on probing.
Correlation of rs56102377 with susceptibility to AgP CTLA4 has been identified as an important gene in the pathogenesis of AgP, and researchers have found that the T-in CD28 +17 (T/C) and the A+ in CTLA4 +49 (A/G) genotypes are associated with susceptibility to aggressive periodontal disease [17] . However, the SNPs reported were all located in the coding region of CTLA4, while there have been few investigations concerning the non-coding region of CTLA4. First, we screened the potential SNPs located in the 3'UTR region of CTLA4 and identified possible candidates binding any miRNA which has been shown to have a possible association with the polymorphism in a public database. In our results, the only SNP located in the 3'UTR region of CTLA4 was rs56102377, which may be associated with interrupting miR-105 binding to CTLA4. Table 2 , the results of Chi-square statistical analysis showed that the genotype distribution of rs56102377 was in Hardy-Weinberg equilibrium in the healthy control group (P = 0.54). Logistic regression analysis results revealed that individuals with the GA and AA genotype were significantly associated with AgP risk (OR = 0.62, 95% CI = 1.11-1.34 and OR = 0.77, 95% CI = 1.25-1.71; P = 0.015), indicating that the GA and AA genotypes presented a significantly decreased risk of AgP compared to the GG genotype. In addition, the A carrier also indicated a decreased risk (P = 0.03) with OR = 0.68, 95% CI = 1.19-1.64. All ORs were adjusted for sex, age, and smoking status, probing depth, attachment loss, and bleeding on probing. 
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Stratified analysis of SNP rs56102377 in AgP patients
A stratified analysis was performed between the distributions of patients with different genotypes and the clinical parameters of AgP (Table 3) . A significant association was found between the rs56102377 genotype and clinical attachment loss and probing bleeding. Compared to GG homozygotes, the carriers of GA and AA genotypes presented with more attachment loss and probing bleeding, which indicated that SNP rs56102377 located in the 3'UTR of CTLA4 may serve as a protective factor in the pathogenesis of AgP.
Interaction of miR-105 with SNP rs56102377 in CTLA4
Based on the distributions of SNP rs56102377 in patients and controls, we hypothesized that the expression of CTLA4 might be dysregulated. We assumed that the SNP rs56102377 might affect the expression of CTLA4, as the speculated location of this SNP was in the binding site of miR-105. The detailed binding site of miR-105 in the 3'UTR of CTLA4 is shown in Fig.  1A , both wild type (with allele G) and mutant type (with allele A) with full length CTLA4 cloned into the pGL3 plasmid tagged with luciferase. When periodontal ligament cells were co-transfected with miR-105 mimics with either wild-type or mutant type CTLA4 allele, the expression of CTLA4 was decreased in cells treated with wild-type CTLA4 compared to mutant type or the control group (Fig. 1B) . The expression of miR-105 in the serum samples revealed that miR-105 was upregulated in AgP (Fig. 1C) . Thus, it might be reasonable to assume that the increased level of miR-105 could suppress CTLA4 level by binding to its 3'UTR region, while the SNP located in the binding sites might cause incapacitation, resulting in higher expression of CTLA4.
Discussion
There is increasing evidence that SNPs located in the binding sites of miRNAs (miRSNPs) may cause a reduction or increase in the translation of the target mRNA by affecting the binding of a miRNA to its target genes, thus altering the susceptibility to disease [22, 23] . Researchers have found that the rs2910164 polymorphism in the miR-146a precursor sequence may influence the susceptibility of the Chinese population to gastric cancer, while the SNPs rs4143815 and rs4819388 in the 3'UTRs of B7-H1 and B7-H2 genes are significantly related to the occurrence of gastric cancer [24, 25] . In this study, we found that CTLA4 with SNP rs56102377 resulting in a GA or AA genotype is associated with a significantly lower rate of AgP compared to the GG genotype. We also found that SNP rs56102377 located in the binding sites of increased circulating miR-105 played an important role in the development of AgP by disrupting the inhibitory role of miR-105 on CTLA4 expression.
The 2q33 chromosomal region bears a cluster of genes, including the CD28, CTLA4, and inducible T-cell costimulator (ICOS), with related functions in T-cell immune regulation. Several SNPs have been identified in the promoter region of the human CTLA4 gene (+1722 T/C, +1661 A/G, +318 C/T) and in exon 1 (+49 G/A), some of which are related to differences in CTLA4 expression or have been associated with susceptibility to autoimmune and infectious diseases [12] . CTLA4 plays a significant role in regulating peripheral T-cell tolerance and attenuating T-cell response. CTLA4/B7 interactions block T-cell activation and promote T-cell death or apoptosis. CTLA4 suppresses the proliferation of T-cells in response to periodontopathogens. The present finding suggests that the presence of a native CTLA4 molecule on the surface of Tregs in the normal population harboring an A allele would produce appropriate regulatory/inhibitory responses which control or attenuate inflammatory responses against periodontopathogens or antigens while bearing a G allele in this position would not. 
Conclusion
In summary, we found a functional SNP located in the 3'UTR of CTLA4 which might cause incapacitation binding of miR-105, thus resulting in an increased level of CTLA4 in AgP patients. Further, SNP rs56102377 in CTLA4 may act as a protective factor in the pathogenesis of AgP.
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